2021
DOI: 10.1016/j.jhin.2021.09.011
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance

Abstract: Background The impact of the coronavirus disease (COVID-19) pandemic on antimicrobial resistance (AMR) is a major concern. Aim To compare the number of patients and isolation rate of antimicrobial-resistant bacteria before and after the beginning of the COVID-19 pandemic using the comprehensive national surveillance data. Methods We utilized comprehensive surveillance data, collected in the Japan Nosocomial Infections Surveillance program, wh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
21
2
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(25 citation statements)
references
References 26 publications
1
21
2
1
Order By: Relevance
“…Our data were from a single hospital based in Lombardy, an area where the prevalence of MDR bacteria was very high even before COVID-19 pandemic. Either of these factors may partially explain the differences between our results and those from other geographical areas, where the incidence of MDR HAI declined during COVID-19 period [ 4 , 6 , 8 ]. Nevertheless, our data show the potential for MDR bacteria to cause infections in COVID-19 patients.…”
contrasting
confidence: 74%
See 1 more Smart Citation
“…Our data were from a single hospital based in Lombardy, an area where the prevalence of MDR bacteria was very high even before COVID-19 pandemic. Either of these factors may partially explain the differences between our results and those from other geographical areas, where the incidence of MDR HAI declined during COVID-19 period [ 4 , 6 , 8 ]. Nevertheless, our data show the potential for MDR bacteria to cause infections in COVID-19 patients.…”
contrasting
confidence: 74%
“…In particular, they found a significant increase in Acinetobacter baumannii infections in 2020 compared to 2019, and a consequent increase in the empiric prescription of polymyxins. To date, the impact of COVID-19 pandemic on the occurrence of multidrug-resistant (MDR) bacteria has been evaluated in several reports [ [2] , [3] , [4] , [5] ]; in particular, the longer duration of antimicrobial therapy for the management of respiratory complications of COVID-19 infection may have a devastating impact on infection control, leading to possible outbreaks of MDR bacteria in hospitals. Further, data on the increased incidence of specific MDR Enterobacterales (e.g.…”
mentioning
confidence: 99%
“…Bakterije kao što su Staphylococcus aureus, MRSA, Streptococcus pneumoniae i Streptococcus pneumoniae rezistentan na penicilin, izolovane su u manjem broju tokom pandemije. Smatra se da su za ovo odgovorni: pojačana upotreba sredstava za dezinfekciju i pranje ruku, smanjenje socijalnih kontakata, nošenje maski, kao i povremeno zatvaranje školskih ustanova [37,38]. Sa druge strane, bakterije kao što su Escherichia coli i Klebsiella pneumoniae (posebno Escherichia coli rezistentna na treću generaciju cefalosporina kao i Klebsiella pneumoniae rezistentna na treću generaciju cefalosporina) izolovane su u većem broju, i takođe su imale proširen spektar antibiotske rezistencije tokom pandemije [37].…”
Section: Discussionunclassified
“…Bacteria such as Staphylococcus aureus, MRSA, Streptococcus pneumoniae, and penicillin-resistant Streptococcus pneumoniae have been isolated in smaller numbers during the pandemic. It is believed that the increased use of disinfectants, hand washing, the limitation of social contacts, wearing face masks, as well as the occasional closing of schools are responsible for this [37,38]. On the other hand, bacteria such as Escherichia coli and Klebsiella pneumoniae (especially Escherichia coli and Klebsiella pneumoniae resistant to 3 rd generation cephalosporins) have been isolated in greater percentages and have also demonstrated an extended spectrum of antibiotic resistance during the pandemic [37].…”
Section: Antimikrobna Rezistencija Tokom Pandemije Kovid-19 Infekcijementioning
confidence: 99%
“…As a matter of fact, many previous studies were also faced with a shortage or loss of available data (i.e., insufficient pediatrics data) [54][55][56]. Moreover, insufficient knowledge of the data or dynamics would lead to invalidity and unreliability of responses to COVID-19 [57]. Therefore, we strongly suggest that public health authorities should disclose more representative and reliable data [58,59].…”
Section: Limitations and Future Workmentioning
confidence: 96%